Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miRNA‑384‑5p regulates the progression of Parkinson's�disease by targeting SIRT1 in mice and SH‑SY5Y cell
Hongli Tao, Yan Liu, Yingjuan Hou
International Journal of Molecular Medicine (2019)
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Resveratrol attenuates manganese-induced oxidative stress and neuroinflammation through SIRT1 signaling in mice
Lin Cong, Meng‐Yu Lei, Zhiqi Liu, et al.
Food and Chemical Toxicology (2021) Vol. 153, pp. 112283-112283
Closed Access | Times Cited: 75
Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
Efthalia Angelopoulou, Yam Nath Paudel, Sokratis G. Papageorgiou, et al.
Brain Sciences (2022) Vol. 12, Iss. 2, pp. 175-175
Open Access | Times Cited: 56
Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators
Hui Xu, Yiyang Liu, Lin-Seng Li, et al.
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 794-794
Open Access | Times Cited: 26
FoxO1 as a tissue-specific therapeutic target for type 2 diabetes
Nicole A. Teaney, Nicole E. Cyr
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 25
Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease
Rui Wang, Hongyang Sun, Guanghui Wang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7182-7182
Open Access | Times Cited: 39
Curcumin protects against rotenone-induced Parkinson's disease in mice by inhibiting microglial NLRP3 inflammasome activation and alleviating mitochondrial dysfunction
Long Xu, Liping Hao, Jing Yu, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e16195-e16195
Open Access | Times Cited: 14
Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1
Ruike Wang, Yingying Wu, Rundong Liu, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 4, pp. 537-553
Closed Access | Times Cited: 21
miRNA in Parkinson's disease: From pathogenesis to theranostic approaches
Ajay Elangovan, Dhivya Venkatesan, Priyanka Selvaraj, et al.
Journal of Cellular Physiology (2022) Vol. 238, Iss. 2, pp. 329-354
Closed Access | Times Cited: 20
Aberrant expression of long noncoding RNAs regulates inflammasome activation via oxidative stress: A novel mechanism for neuroinflammation and neurodegeneration in Parkinson's disease
Irene Mary Praveen, Calivarathan Latchoumycandane
Clinical and Experimental Neuroimmunology (2025)
Closed Access
Values of epigenetic markers in Parkinson's disease as biomarkers and therapeutic targets: A narrative review
Dhruv Parikh, Manan Shah
NeuroMarkers. (2025), pp. 100037-100037
Open Access
Metformin Effect Against Rotenone-Induced Parkinsonism-Like Symptoms in a Mouse Model
Israa Hussein Al-Mammory, Ghaith Ali Jasim, Wassan Abdulkareem Abbas
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2025) Vol. 8, Iss. 2, pp. 47-52
Closed Access
Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease
Shubhra Acharya, Antonio Salgado‐Somoza, Francesca Maria Stefanizzi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6513-6513
Open Access | Times Cited: 26
Crosstalk between regulatory non-coding RNAs and oxidative stress in Parkinson’s disease
Hantao Zhang, Xiaoyan Liu, Yi Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 14
Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research
Mohammad Ahmed Khan, Nafis Haider, Tanveer Singh, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 3, pp. 873-919
Closed Access | Times Cited: 8
Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1
Mirte Scheper, Anand M. Iyer, Jasper J. Anink, et al.
Neuropathology and Applied Neurobiology (2022) Vol. 49, Iss. 1
Open Access | Times Cited: 13
miR-15b-5p transcription mediated by CREB1 protects against inflammation and apoptosis in Parkinson disease models by inhibiting AXIN2 and activating Wnt/β-catenin
Tianyi Liu, Guozhong Li
Journal of Neuropathology & Experimental Neurology (2023) Vol. 82, Iss. 12, pp. 995-1009
Closed Access | Times Cited: 7
Long noncoding RNA BACE1-antisense transcript plays a critical role in Parkinson’s disease via microRNA-214-3p/Cell death-inducing p53-target protein 1 axis
Lina Li, Hongjuan Wang, Huicang Li, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 10889-10901
Open Access | Times Cited: 11
MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
Sushmaa Chandralekha Selvakumar, K. Auxzilia Preethi, Deusdedit Tusubira, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 11
Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
Alshimaa Magdy, Eman A. E. Farrag, Shereen Hamed, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 10
miR-126-5p Targets SP1 to Inhibit the Progression of Parkinson’s Disease
Yanping Han, Zhijun Liu, Hong-Hui Bao, et al.
European Neurology (2022) Vol. 85, Iss. 3, pp. 235-244
Closed Access | Times Cited: 9
Mesenchymal stem cell exosomes rich in miR-23b-3p affect the Wnt signaling pathway and promote neuronal autophagy to alleviate PD symptoms
Peng Geng, Yanghong Zou, Jinghui Li, et al.
Neuroscience Letters (2023) Vol. 814, pp. 137437-137437
Open Access | Times Cited: 5
Gut Microbiota Defined Epigenomes of Alzheimer’s and Parkinson’s Diseases Reveal Novel Targets for Therapy
Shabnam Nohesara, Hamid M. Abdolmaleky, Sam Thiagalingam, et al.
Epigenomics (2023) Vol. 16, Iss. 1, pp. 57-77
Closed Access | Times Cited: 3
The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases
Thanga Harini Sundaramoorthy, Isabel Castanho
Epigenetics Insights (2022) Vol. 15
Open Access | Times Cited: 5
Mechanistic Evaluation of miRNAs and Their Targeted Genes in the Pathogenesis and Therapeutics of Parkinson’s Disease
Tania Arora, Gaurav Kumar Sharma, Vikash Prashar, et al.
Molecular Neurobiology (2024)
Closed Access
Targeting sirtuins in neurological disorders: A comprehensive review
Sen-Yu Zhang, Ni Yang, Peng-Hui Hao, et al.
International Journal of Biological Macromolecules (2024) Vol. 292, pp. 139258-139258
Closed Access
Page 1 - Next Page

Scroll to top